Everand Logo

Welcome to Everand!

  • Discover millions of ebooks, audiobooks, and so much more with a free trial

    From $11.99/month after trial. Cancel anytime.

    Mental and Behavioral Disorders Due to Use of Cannabinoids
    Mental and Behavioral Disorders Due to Use of Cannabinoids
    Mental and Behavioral Disorders Due to Use of Cannabinoids
    Ebook141 pages1 hour

    Mental and Behavioral Disorders Due to Use of Cannabinoids

    By Dr. Spineanu Eugenia

    ()

    Read preview

    About this ebook

    Discover the intricate link between cannabinoids and mental health in our comprehensive exploration of "Mental and Behavioral Disorders Due to Use of Cannabinoids." Delve into the nuanced interplay between cannabinoid consumption and mental well-being, uncovering the complexities that underlie various mental health conditions.

    Our treatise meticulously dissects the impact of cannabinoids on mental and behavioral health, offering an in-depth analysis rooted in medical and biochemical insights. Explore the mechanisms through which cannabinoids interact with the brain, shedding light on the brain structures, neurotransmitter systems, and endocannabinoid functions affected by their usage.

    From anxiety and mood disorders to psychotic manifestations and cognitive impairments, we unveil the spectrum of mental health complications associated with cannabinoid consumption. Each chapter navigates through specific disorders, elucidating their symptoms, biochemical pathways, and the intricate balance disrupted by cannabinoids.

    LanguageEnglish
    PublisherDr. Spineanu Eugenia
    Release dateSep 9, 2024
    ISBN9798227188021
    Mental and Behavioral Disorders Due to Use of Cannabinoids

    Read more from Dr. Spineanu Eugenia

    Related to Mental and Behavioral Disorders Due to Use of Cannabinoids

    Related ebooks

    Medical For You

    View More
    View More

    Related podcast episodes

    Related articles

    • UNLIMITED

      Breaking Free With CBD

      May 30, 2018

      Breaking Free With CBD
      4 min read

    • UNLIMITED

      Respect The research

      Jun 7, 2022

      Respect The research
      4 min read

    • UNLIMITED

      New Targeted Therapeutics Herald A Medical Revolution

      Oct 20, 2023

      With the development of targeted therapeutics in the cannabis industry, the field of medicine is undergoing a profound transformation. Traditional medicine frequently adopts a one-size-fits-all philosophy, when treatments are given based on general d

      2 min read

    • UNLIMITED

      Flying High

      Jan 23, 2022

      Flying High
      5 min read

    • UNLIMITED

      Green Relief

      Mar 30, 2020

      Green Relief
      3 min read

    • UNLIMITED

      Cannabis And Mental Health

      Aug 18, 2023

      For a while now, there's been growing interest in the connection between cannabis and mental health. Endocannabinoids, or body-produced cannabinoids, enzymes and receptors make up the complex network known as the endocannabinoid system (ECS), which c

      2 min read

    • UNLIMITED

      The Major Players

      Jan 23, 2022

      The Major Players
      3 min read

    • UNLIMITED

      Oil On Trouble Waters

      May 24, 2020

      Oil On Trouble Waters
      9 min read

    • UNLIMITED

      CBD, PEA and LDN

      Jul 15, 2021

      CBD, PEA and LDN
      3 min read

    • UNLIMITED

      CBD oil in Aotearoa WHAT YOU NEED TO KNOW

      Mar 17, 2019

      Cannabis has been on the radar of many New Zealanders recently, with the government passing the Medicinal Cannabis Amendment Bill in December 2018, and a referendum on recreational cannabis use planned for 2020. One of the critical elements of the am

      3 min read

    • UNLIMITED

      The Dope On Sleep

      Dec 9, 2024

      The Dope On Sleep
      3 min read

    • UNLIMITED

      Lessons From A Scottish Grandmother

      Aug 5, 2019

      For many, a world free from anxiety is a dream, but to one Scottish woman, it’s reality. Jo Cameron, now 71, has lived an anxiety and pain-free life. To Cameron, an epidural is merely a tickle, and the anxiety that should accompany childbirth or surg

      4 min read

    • UNLIMITED

      Medicinal CBD update

      Jan 18, 2024

      Medicinal CBD update
      2 min read

    • UNLIMITED

      A Deep Dive Into Hexahydrocannabinol

      Feb 16, 2024

      The spotlight has shifted in research towards exploring substitutes for △9-tetrahydrocannabinol (THC), with hexahydrocannabinol (HHC) emerging as a prominent figure in this dynamic landscape. To guide us through the nuances of this fascinating subjec

      2 min read

    • UNLIMITED

      CANNABIS (CBD) & fertility

      May 26, 2020

      Q How will Cannabis (CBD) affect my fertility? Will it make me more or less fertile? A DR CARMEN JAMES ANSWERS: In the current climate of legalisation of cannabis in South Africa and around the world, use is expected to increase. The majority of us

      3 min read

    • UNLIMITED

      Let’s Talk About Cbd

      Jan 24, 2020

      Let’s Talk About Cbd
      3 min read

    • UNLIMITED

      CBD Could It Work For You?

      Mar 19, 2020

      CBD Could It Work For You?
      4 min read

    • UNLIMITED

      Blunt Advice

      Oct 13, 2022

      It can make you feel good. It’s cheaper than therapy. And it’s now legal for recreational use in 19 states. So it’s not surprising that my patients keep asking me, “A little pot can’t hurt, right?” Nobody ever wants to hear a pause right after they d

      3 min read

    • UNLIMITED

      What Is The Process?

      Aug 25, 2022

      What Is The Process?
      6 min read

    • UNLIMITED

      Blunt Advice

      Jan 8, 2023

      WEED CAN BE RELAXING. It can make you feel good. It's cheaper than therapy. And it's now legal for recreational use in 19 states of the US (though still largely illegal in Australia, with the qualified exception of the ACT). So it's not surprising th

      3 min read

    • UNLIMITED

      Fact Sheet CBD Oil

      Jun 16, 2021

      Fact Sheet CBD Oil
      1 min read

    Related categories

    Reviews for Mental and Behavioral Disorders Due to Use of Cannabinoids

    0 ratings

    0 ratings0 reviews

    What did you think?

    Tap to rate

    Review must be at least 10 words

      Book preview

      Mental and Behavioral Disorders Due to Use of Cannabinoids - Dr. Spineanu Eugenia

      Chapter I. Introduction to Cannabinoids and Their Effects

      In recent decades, the pervasive use of cannabinoids, derived from the cannabis plant, has sparked a profound interest in their multifaceted effects on the human brain and behavior. The evolving landscape of societal attitudes and legal frameworks surrounding cannabis use has propelled its consumption into mainstream culture, igniting both therapeutic promise and concerns regarding its potential adverse effects on mental health.

      This treatise endeavors to comprehensively explore the intricate interplay between cannabinoids and mental well-being, offering a nuanced understanding of the physiological, biochemical, and psychological dimensions underlying the development of mental and behavioral disorders consequent to cannabinoid use.

      Cannabinoids, comprising an array of compounds, most notably tetrahydrocannabinol (THC) and cannabidiol (CBD), exert their influence through intricate interactions with the endocannabinoid system, a complex network deeply integrated within the neurobiological fabric of the human brain. Understanding the dynamic mechanisms by which cannabinoids modulate neurotransmission, alter cognitive functions, and perturb emotional regulation is fundamental to deciphering the spectrum of mental health outcomes associated with their consumption.

      This treatise embarks on a multidisciplinary journey, traversing the domains of neuroanatomy, pharmacokinetics, psychiatric nosology, and holistic health paradigms. It seeks to delineate the anatomical substrates impacted by cannabinoids, delineate the biochemical pathways mediating their effects, and meticulously delineate the nuanced spectrum of mental and behavioral disorders they may incite.

      Moreover, this treatise endeavors to provide a meticulous exposition of the myriad clinical manifestations arising from cannabinoid-induced perturbations in brain function, elucidating the diverse symptomatology that encompasses altered cognition, affect, and behavior. Additionally, it aims to elucidate diagnostic modalities, treatment strategies, and preventative measures aimed at mitigating the deleterious impact of cannabinoid-related disorders.

      Amidst burgeoning societal dialogue and evolving scientific inquiry, this treatise aspires to offer a comprehensive synthesis of current knowledge, paving a path toward enhanced understanding, informed clinical practice, and novel research avenues. Through this holistic exploration, we endeavor to navigate the intricate nexus between cannabinoids and mental health, thereby fostering a nuanced comprehension essential to promote well-being amidst the complex tapestry of cannabinoid usage.

      1.Overview of Cannabinoids

      Cannabinoids, a diverse class of compounds found in the cannabis plant (Cannabis sativa), have garnered immense scientific and public interest due to their multifaceted effects on the human body and mind. These compounds encompass a spectrum of chemical constituents, with over 100 cannabinoids identified to date. Among the most prominent are delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD), each exerting distinct pharmacological actions, mechanisms of action, and potential therapeutic applications.

      1. Classification and Types of Cannabinoids

      Cannabinoids are broadly classified into three categories:

      Phytocannabinoids: Naturally occurring cannabinoids found in the cannabis plant. THC and CBD are the most abundant and extensively studied phytocannabinoids. Other notable ones include cannabinol (CBN), cannabigerol (CBG), and cannabichromene (CBC).

      Endocannabinoids: Endogenous cannabinoids produced within the human body. Anandamide (AEA) and 2-arachidonoylglycerol (2-AG) are the primary endocannabinoids identified so far. They act as neurotransmitters and play vital roles in modulating various physiological processes.

      Synthetic Cannabinoids: Man-made compounds designed to mimic the effects of natural cannabinoids. These synthetic analogs often possess enhanced potency or altered pharmacokinetic properties compared to their natural counterparts. Examples include HU-210 and JWH-018.

      2. Cannabinoid Receptors and the Endocannabinoid System (ECS)

      The pharmacological effects of cannabinoids are primarily mediated through interaction with cannabinoid receptors, notably cannabinoid receptor type 1 (CB1) and cannabinoid receptor type 2 (CB2). CB1 receptors are primarily found in the central nervous system, while CB2 receptors are predominantly located in immune cells and peripheral tissues.

      The endocannabinoid system (ECS), comprising cannabinoid receptors, endogenous cannabinoids, and enzymes responsible for their synthesis and degradation, plays a pivotal role in maintaining homeostasis within the body. This intricate signaling network regulates a myriad of physiological functions, including mood, memory, pain sensation, appetite, and immune response.

      3. Mechanisms of Action

      Cannabinoids exert their effects by interacting with cannabinoid receptors and modulating neurotransmitter release. THC, for instance, primarily binds to CB1 receptors, leading to a cascade of intracellular events that alter neuronal excitability and neurotransmitter release. This mechanism underlies the psychotropic effects of THC, including euphoria, altered perception, and impairment of cognitive functions.

      CBD, on the other hand, exhibits a more complex pharmacological profile. While it has a low affinity for cannabinoid receptors, it modulates their activity indirectly and interacts with other receptor systems, such as serotonin and TRPV1 receptors, contributing to its diverse pharmacological effects. CBD is renowned for its potential anticonvulsant, anxiolytic, and anti-inflammatory properties, among others, without inducing the intoxicating effects associated with THC.

      4. Sources and Extraction of Cannabinoids

      Phytocannabinoids are predominantly derived from the cannabis plant. Different strains of cannabis yield varying concentrations of cannabinoids, with THC-rich strains favored for recreational purposes and CBD-rich strains sought after for their purported therapeutic benefits.

      Extraction methods play a crucial role in isolating cannabinoids for various purposes. Techniques such as solvent extraction, CO2 extraction, and chromatography are employed to obtain pure cannabinoids or cannabinoid-rich extracts used in pharmaceuticals, wellness products, and research.

      5. Therapeutic Potential and Medical Applications

      Cannabinoids have garnered attention for their potential therapeutic applications across a spectrum of medical conditions. CBD, in particular, has shown promise in the treatment of epilepsy, anxiety disorders, chronic pain, and neurodegenerative diseases. Epidiolex, a CBD-based medication, has gained FDA approval for the treatment of certain types of epilepsy.

      THC-based pharmaceuticals, such as dronabinol and nabilone, have been prescribed for managing chemotherapy-induced nausea and vomiting and stimulating appetite in patients with wasting syndrome associated with HIV/AIDS.

      6. Legal and Regulatory Landscape

      The legal status of cannabinoids varies widely across jurisdictions. While some countries have legalized cannabis for medicinal and/or recreational use, others maintain stringent regulations prohibiting or restricting its use. This dichotomy in legal frameworks poses challenges and complexities in conducting research, accessing treatment, and implementing public health policies related to cannabinoids.

      7. Safety, Adverse Effects, and Potential Risks

      Despite the therapeutic potential of cannabinoids, their use is not without risks. THC, in particular, is associated with psychotropic effects, including anxiety, paranoia, and impaired cognition, especially when consumed in high doses. Long-term heavy cannabis use has been linked to an increased risk of developing psychosis and other mental health disorders, although causality remains a subject of debate.

      CBD, considered relatively safe with few reported adverse effects, may interact with certain medications, affecting their metabolism via the cytochrome P450 system, necessitating caution in co-administration with other drugs.

      2.Types of Cannabinoids: An In-Depth Examination

      Cannabinoids, the diverse chemical compounds found within the cannabis plant, exhibit a wide array of pharmacological effects and therapeutic potential. Among the multitude of cannabinoids identified, several stand out for their prominence in research, medical applications, and societal impact.

      1. Delta-9-Tetrahydrocannabinol (THC)

      Delta-9-tetrahydrocannabinol (THC) is arguably the most well-known and extensively studied cannabinoid. It is primarily responsible for the psychoactive effects associated with cannabis consumption. THC exerts its effects by binding to cannabinoid receptors, particularly CB1 receptors in the central nervous system, initiating a cascade of neurochemical events leading to altered perception, mood changes, and impairment of cognitive functions.

      Beyond its recreational use, THC has garnered interest for its therapeutic potential. It demonstrates analgesic properties, aiding in pain management for conditions like neuropathic pain and chronic pain syndromes. Additionally, THC-based pharmaceuticals, such as dronabinol and nabilone, have

      Enjoying the preview?
      Page 1 of 1